Search Results 901-910 of 16076 for pharmacogenetics
This phase I trial identifies the best dose, possible benefits, and/or side effects of duvelisib in combination with nivolumab in treating patients with ...
About this study. The purpose of this study is to identify clinical demographics of patients initiated on inotropes during a heart failure admission and ...
The purpose of this study is to see how well study drug works at treating people with fungal diseases that are refractory to or intolerant of Standard ...
The purpose of this study is to determine if an investigational treatment (Maribavir) is safe and effective in treating transplant recipient patients with ...
The objective is to obtain and report outcome data for adult subjects who received systemic antifungal therapy (AFT) for the treatment of invasive mucormycosis ...
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
About this study. This study will test whether immune functions in individual cancer patients can be characterized in a quantitative manner using new ...
The purpose of this study is to create a patient-centered research partnership with a stakeholder advisory group (SAB) to adapt the Duke Transgender and Gender ...
The main objective is to compare prebiotic therapy with placebo for the prevention of pouchitis after closure of diverting ileostomy in patients with an ileal ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your GivingTuesday gift can go 2X as far.